You searched for "elective"

2025 results found

Endo-illumination-aided SB combined with IVT hyaluronate for RRD

The authors report a retrospective non-randomised control trial that evaluated the efficacy and safety of 25-gauge illumination-aided scleral buckling (SB) combined with hyaluronate injection for the treatment of rhegmatogenous retinal detachment (RRD). Forty-five cases were included in this study. Twenty-five...

Cost-effectiveness of orthoptic-delivered screening versus school nurse screening

The authors describe a long-term audit of outcomes and costs associated with referrals from two established neighbouring school-entry vision screening services in the UK over one academic year with one adhering to national UK screening guidelines more closely than the...

Association between neurodegeneration and macular perfusion in the progression of diabetic retinopathy

In this prospective three-year longitudinal study, the authors aimed to explore the relation between retinal neurodegenerative changes and vessel closure (VC) in individuals with non-proliferative diabetic retinopathy (NPDR). The participants included 74 individuals with type 2 diabetes, NPDR, and Early...

Outcome of secondary intraocular lens implantation-conventional 23- vs. modified 27-gauge vitrectomy port anchor fixation

This retrospective case study series evaluated the outcome of a secondary intraocular lens (IOL) implantation technique of a Carlevale IOL (Soleko IOL Division, Italy) with either a conventional 23- or a modified 27-gauge (-g) vitrectomy port used as anchor fixation....

Results of vitrectomy in epiretinal membranes secondary to retinal vein occlusions

This retrospective, observational multicentre study investigated the anatomic and functional results of vitrectomy associated with the peeling of secondary epiretinal membranes (ERM) in patients with retinal vein occlusion (RVO) and determined the prognostic factors of surgical outcomes. Data was collected...

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Sight Sciences Glaucoma Fellows Academy, Birmingham

Saturday 7 October saw Sight Sciences hold their inaugural UK Glaucoma Fellows Academy training day.

Haag-Streit UK look forward to exhibiting at 100% Ophthalmology 2024

Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce it will be exhibiting at 100% Ophthalmology in February 2024.

Sight Sciences Celebrates 150th Certified UK OMNI Surgeon

Sight Sciences is proud to announce that 150 ophthalmic surgeons in the United Kingdom are now certified to use the OMNI® Surgical System. This milestone was marked by the recent certification of Ms. Diana Urbaneja, Consultant Ophthalmic Surgeon at University...

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...

AI-Based devices in national screening programmes: barriers and challenges

Diabetic retinopathy (DR) may have long-term complications and is recorded as a leading cause of blindness. National DR screening programmes have effectively reduced severe visual loss by timely detection and subsequent treatment of sight-threatening proliferative DR and diabetic macular oedema....

MacuMira and Keeler announce strategic partnership to expand dry AMD therapy

Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...